Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dwight H Owen
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
193 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Cedars-Sinai Cancer - Tarzana
Tarzana, California, United States
- Torrance Memorial Physician Network - Cancer Care
Torrance, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Midstate Medical Center
Meriden, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe South Coastal Health Campus
Millville, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Emory Decatur Hospital
Decatur, Georgia, United States
- Emory Johns Creek Hospital
Johns Creek, Georgia, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Illinois Cancercare-Dixon
Dixon, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, United States
- Northwestern Medicine Glenview Outpatient Center
Glenview, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Aug 2025
- Primary completion
- 30 Jun 2028
- Completion
- 30 Jun 2028
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 630
- Registry id
- NCT06732401
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.